Mirati Therapeutics downgraded to Neutral from Buy at Citi
PremiumThe FlyMirati Therapeutics downgraded to Neutral from Buy at Citi
9M ago
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
Premium
The Fly
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
11M ago
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
Premium
The Fly
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
11M ago
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
PremiumPress ReleasesMirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
11M ago
MRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11M ago
Mirati Therapeutics receives MHRA approval for KRAZATI
Premium
The Fly
Mirati Therapeutics receives MHRA approval for KRAZATI
11M ago
William Blair healthcare/biotech analysts hold analyst/industry conference call
PremiumThe FlyWilliam Blair healthcare/biotech analysts hold analyst/industry conference call
11M ago
William Blair healthcare/biotech analysts hold analyst/industry conference call
Premium
The Fly
William Blair healthcare/biotech analysts hold analyst/industry conference call
11M ago
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
Premium
The Fly
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100